Kelvin K. Womack - 27 Apr 2023 Form 4 Insider Report for Cardiovascular Systems Inc

Role: Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Kelvin K. Womack pursuant to Power of Attorney previously filed.
Issuer symbol: N/A
Transactions as of: 27 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 27 Apr 2023, 16:35:24 UTC
Previous filing: 09 Aug 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CSII	Restricted Stock Units	Disposed to Issuer	$0	-16,734	-100%	$0.000000^*	0	27 Apr 2023	Common Stock	16,734		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Kelvin K. Womack is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Pursuant to the Agreement and Plan of Merger by and among Cardiovascular Systems, Inc., a Delaware corporation, Abbott Laboratories, an Illinois corporation, and Cobra Acquisition Co., a Delaware corporation (the "Merger Agreement"), each unvested restricted stock unit became fully vested immediately prior to the effective time of the merger. Restricted stock units were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes.

Content

Pursuant to the Agreement and Plan of Merger by and among Cardiovascular Systems, Inc., a Delaware corporation, Abbott Laboratories, an Illinois corporation, and Cobra Acquisition Co., a Delaware corporation (the "Merger Agreement"), each unvested restricted stock unit became fully vested immediately prior to the effective time of the merger. Restricted stock units were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes.